Inozín (Slovak Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inozín" in Slovak language version.

refsWebsite
Global rank Slovak rank
2nd place
7th place
4th place
21st place
1st place
8th place
5,225th place
low place
low place
low place
low place
low place
1,151st place
4,099th place
low place
low place
low place
low place
234th place
71st place
low place
low place

bostonlifesciences.com

  • Boston Life Sciences Announces Issuance of Inosine Patent for Treatment of Spinal Cord Injury [online]. November 17, 2003. Dostupné online. Archivované 2005-09-03 z originálu.

clinicaltrials.gov

  • Treatment of Multiple Sclerosis Using Over the Counter Inosine - Full Text View - ClinicalTrials.gov [online]. clinicaltrials.gov, [cit. 2021-12-10]. Dostupné online. (po anglicky)
  • Safety of Urate Elevation in Parkinson's Disease - Full Text View - ClinicalTrials.gov [online]. clinicaltrials.gov, [cit. 2021-12-10]. Dostupné online. (po anglicky)

doi.org

dx.doi.org

  • ISSN exercise & sports nutrition review update: research & recommendations. Journal of the International Society of Sports Nutrition, August 2018, s. 38. DOI10.1186/s12970-018-0242-y. PMID 30068354.
  • Secondary degeneration reduced by inosine after spinal cord injury in rats. Spinal Cord, July 2006, s. 421–6. DOI10.1038/sj.sc.3101878. PMID 16317421.
  • Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proceedings of the National Academy of Sciences of the United States of America, June 2002, s. 9031–6. DOI10.1073/pnas.132076299. PMID 12084941.
  • The treatment of multiple sclerosis with inosine. Journal of Alternative and Complementary Medicine, June 2009, s. 619–25. DOI10.1089/acm.2008.0513. PMID 19425822.
  • Identification of inosine as an endogenous modulator for the benzodiazepine binding site of the GABAA receptors. Journal of Biomedical Science, July 1998, s. 274–80. DOI10.1007/bf02255859. PMID 9691220.
  • Advantage of using inosine at the 3' termini of 16S rRNA gene universal primers for the study of microbial diversity. Applied and Environmental Microbiology, November 2006, s. 6902–6. DOI10.1128/AEM.00849-06. PMID 16950904.
  • An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell, December 1988, s. 1089–98. DOI10.1016/0092-8674(88)90253-x. PMID 3203381.
  • Identification of feeding stimulants for juvenile eel.. Bulletin of the Japanese Society of Scientific Fisheries, 1984, s. 645–651. DOI10.2331/suisan.50.645.

fedem.org

  • Immune mediated injury, oxidative toxicity and excitotoxicity in multiple sclerosis. Possibilities for immune modulation and neuroprotection [online]. . Dostupné online. Archivované 2007-03-11 z originálu.

geocities.com

michaeljfox.org

foxtrialfinder.michaeljfox.org

  • Safety of Urate Elevation in Parkinson's Disease [online]. Fox Trial Finder, 2018. Dostupné online.

michaeljfox.org

  • KUHL, Maggie McGuire. Inosine Trial Secures Phase III Funding to Study Effect on Slowing Parkinson's [online]. Michael J. Fox Foundation, September 1, 2015. Dostupné online.

nature.com

  • LOU, Kai-Jye. The inosine conundrum (Alseres Pharmaceuticals Inc.). Nature SciBX, 2009. Dostupné online.

nih.gov

ncbi.nlm.nih.gov

  • ISSN exercise & sports nutrition review update: research & recommendations. Journal of the International Society of Sports Nutrition, August 2018, s. 38. DOI10.1186/s12970-018-0242-y. PMID 30068354.
  • Secondary degeneration reduced by inosine after spinal cord injury in rats. Spinal Cord, July 2006, s. 421–6. DOI10.1038/sj.sc.3101878. PMID 16317421.
  • Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proceedings of the National Academy of Sciences of the United States of America, June 2002, s. 9031–6. DOI10.1073/pnas.132076299. PMID 12084941.
  • The treatment of multiple sclerosis with inosine. Journal of Alternative and Complementary Medicine, June 2009, s. 619–25. DOI10.1089/acm.2008.0513. PMID 19425822.
  • Identification of inosine as an endogenous modulator for the benzodiazepine binding site of the GABAA receptors. Journal of Biomedical Science, July 1998, s. 274–80. DOI10.1007/bf02255859. PMID 9691220.
  • Advantage of using inosine at the 3' termini of 16S rRNA gene universal primers for the study of microbial diversity. Applied and Environmental Microbiology, November 2006, s. 6902–6. DOI10.1128/AEM.00849-06. PMID 16950904.
  • An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell, December 1988, s. 1089–98. DOI10.1016/0092-8674(88)90253-x. PMID 3203381.

vitanetonline.com

  • IN, Log; OUT, Log; ACCOUNT, My. VitaNet®, LLC [online]. vitanetonline.com, [cit. 2021-12-10]. Dostupné online.

web.archive.org

  • Uric Acid In Multiple Sclerosis [online]. WebCite, 2018. Dostupné online. Archivované 2009-10-27 z originálu.
  • Immune mediated injury, oxidative toxicity and excitotoxicity in multiple sclerosis. Possibilities for immune modulation and neuroprotection [online]. . Dostupné online. Archivované 2007-03-11 z originálu.
  • Boston Life Sciences Announces Issuance of Inosine Patent for Treatment of Spinal Cord Injury [online]. November 17, 2003. Dostupné online. Archivované 2005-09-03 z originálu.

whocc.no

  • ATC/DDD Index [online]. World Health Organization Collaborating Centre. Dostupné online.